FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jens Lundgren

Research Profile

Disorders

Living Beings

Procedures

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Europe

Co-author Network

Publications

TOP 3
Lene Ryom; Colette Smith; Signe W Worm; Christoph A Fux; David A Kamara; Ole Kirk; Jens D Lundgren; Amanda Mocroft; Olivier Moranne; Philippe Morlat; Peter Reiss; Michael Ross
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
Helen Kovari; bruno ledergerber; Jens D Lundgren; Philippe Morlat; Kathy Petoumenos; Andrew Phillips; Peter Reiss; Lene Ryom; Caroline A Sabin; Colette Smith; Stéphane De Wit; Eric Fontas; Signe W Worm; Rainer Weber
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.
Daria Podlekareva; F A Post; Vija Riekstina; A M Skrahina; M Bruyand; J A Caylá; Hansjakob Furrer; E Girardi; D Grint; Ole Kirk; M H Losso; Jens D Lundgren; E A Malashenkov; R F Miller; J M Miro; Amanda Mocroft; N Obel; Alexander Panteleev
Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jens Lundgren (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lene Ryom; Colette Smith; Signe W Worm; Christoph A Fux; David A Kamara; Ole Kirk; Jens D Lundgren; Amanda Mocroft; Olivier Moranne; Philippe Morlat; Peter Reiss; Michael Ross
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
The Journal of infectious diseases 2013;207(9):1359-69.
2013: Helen Kovari; bruno ledergerber; Jens D Lundgren; Philippe Morlat; Kathy Petoumenos; Andrew Phillips; Peter Reiss; Lene Ryom; Caroline A Sabin; Colette Smith; Stéphane De Wit; Eric Fontas; Signe W Worm; Rainer Weber
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(6):870-9.
2013: Daria Podlekareva; F A Post; Vija Riekstina; A M Skrahina; M Bruyand; J A Caylá; Hansjakob Furrer; E Girardi; D Grint; Ole Kirk; M H Losso; Jens D Lundgren; E A Malashenkov; R F Miller; J M Miro; Amanda Mocroft; N Obel; Alexander Panteleev
Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2013;17(2):198-206.
2013: Antonella d'Arminio Monforte; Andrew N Phillips; Christian Pradier; Peter Reiss; Lene Ryom; Francois Dabis; Stephane De Wit; Wafaa El-Sadr; Ole Kirk; Mathew G Law; Jens D Lundgren; Rainer Weber; Signe W Worm; Caroline A Sabin
Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events.
AIDS (London, England) 2013;27(3):407-15.
2013: Eva Zetterberg; Jason V Baker; Maria Chini; Josep M Llibre; Jens D Lundgren; Jacqueline Neuhaus; Adrian Palfreeman; Charurut Somboonwit
Platelet count kinetics following interruption of antiretroviral treatment.
AIDS (London, England) 2013;27(1):59-68.
2013: Alison J Rodger; Jan van Lunzen; Pietro Vernazza; Tina Bruun; Simon Collins; Giulio M Corbelli; Vicente Estrada; Jens D Lundgren; Andrew N Phillips
Further research needed to support a policy of antiretroviral therapy as an HIV prevention initiative.
Antiviral therapy 2013;18(3):285-7.
2012: Lars Peters; Peter Reiss; Jürgen K Rockstroh; Helen Sambatakou; Vincent Soriano; Daniel Grint; Anna Grzeszczuk; Ole Kirk; Jens D Lundgren; Amanda Mocroft
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
AIDS (London, England) 2012;26(15):1917-26.
2012: Jeffrey V Lazarus; Jens D Lundgren
"E" is for everything else, not least for expanding HIV testing in Europe.
Bulletin of the World Health Organization 2012;90(9):634-634A.
2012: S W Worm; F Dabis; Antonella d'Arminio Monforte; Stephane De Wit; Wafaa M El-Sadr; Eric Fontas; D A Kamara; M Law; Jens D Lundgren; A Phillips; Peter Reiss; L Ryom; C Sabin; Rainer Weber
Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke.
The Journal of infectious diseases 2012;205(4):535-9.
2012: Justyna D Kowalska; bruno ledergerber; Jens D Lundgren; Amanda Mocroft; Andrew Phillips; Joanne Reekie; Peter Reiss; Antonella d'Arminio Monforte; Jose Gatell; Ole Kirk
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy.
AIDS (London, England) 2012;26(3):315-23.
2012: Amanda Mocroft; Aza Rakhmanova; Peter Reiss; Hanna Trocha; Wendy P Bannister; Antonella d'Arminio Monforte; Martin Fisher; Jose Gatell; Ole Kirk; Justyna D Kowalska; Jens D Lundgren
The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression.
Antiviral therapy 2012;17(7):1291-300.
2012: Daria Podlekareva; Aza Rakhmanova; Joanne Reekie; Elzbieta Bakowska; Jose Gatell; Igor A Karpov; Ole Kirk; Jeffrey V Lazarus; Marcelo H Losso; Jens D Lundgren; Amanda Mocroft
Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study.
BMC infectious diseases 2012;12():229.
2012: Joanne Reekie; Jurgen Rockstroh; Andrzej Horban; Anders Karlsson; Igor Karpov; Ole Kirk; Justyna D Kowalska; Jens D Lundgren; Amanda Mocroft; Aza Rakhmanova
Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study.
PloS one 2012;7(7):e41673.
2012: Jens-Ulrik Stæhr Jensen; Maria Egede Johansen; Jesper Kjaer; Kim Michael Larsen; Anne Øberg Lauritsen; Jesper Løken; Bettina Lundgren; Jens D Lundgren; Thomas Mohr; Lene Ryom Nielsen; Christian Ostergaard; Nanna Reiter; P Søe-Jensen; Morten Steensen; Ditte Gry Strange; Katrin Thormar; Klaus Julius Thornberg; Hamid Tousi; Mads Holmen Andersen; Morten H Bestle; Niels-Erik Drenck; Paul Christian Fjeldborg; Zoe Fox; Jesper Grarup; Lars Hein
Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial.
BMJ open 2012;2(2):e000635.
2012: Alessandro Cozzi-Lepri; Jesper Kjaer; G Kronborg; Jens D Lundgren; Andrew N Phillips; Viktor von Wyl; J R Bogner; A Castagna; Bonaventura Clotet
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*.
HIV medicine 2012;13(1):62-72.
2011: Jens U Jensen; Jesper Kjaer; Kim M Larsen; Anne Ø Lauritsen; Jesper Løken; Bettina Lundgren; Jens D Lundgren; Thomas T Mohr; Christian Ostergaard; Pernille L Petersen; Nanna Reiter; P Søe-Jensen; Morten Steensen; Ditte Strange; Katrin Thormar; Klaus J Thornberg; Hamid Tousi; Mads H Andersen; Morten H Bestle; Niels E Drenck; Paul Fjeldborg; Zoe Fox; Jesper Grarup; Lars Hein; Søren Hestad
Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
Critical care medicine 2011;39(9):2048-58.
2011: Signe W Worm; Antonella d'Arminio Monforte; Stephane De Wit; Wafaa M El-Sadr; Eric Fontas; Nina Friis-Mller; Christoph Fux; David A Kamara; Ole Kirk; Jens D Lundgren; Patrick Mercie; Kathy Petoumenos; Andrew Phillips; Peter Reiss; Caroline Sabin
Elevated triglycerides and risk of myocardial infarction in HIV-positive persons.
AIDS (London, England) 2011;25(12):1497-504.
2011: Alexey Kruk; Jens D Lundgren; Amanda Mocroft; Daria Podlekareva; Aza G Rakhmanova; Wendy Bannister; Nelly P Chentsova; Perre Domingo; Andrzej Horban; Ole Kirk
Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors.
AIDS (London, England) 2011;25(12):1505-13.
2011: Justyna D Kowalska; Matthew Law; Charlotte Lewden; Jens D Lundgren; Amanda Mocroft; Andrew Phillips; Peter Reiss; Caroline Sabin; Jonathan Sterne; Wendy Bannister; Antonella d'Arminio Monforte; Stephane De Wit; Nina Friis-Møller; John Gill; Ole Kirk
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology.
Epidemiology (Cambridge, Mass.) 2011;22(4):516-23.
2011: Signe W Worm; Jens D Lundgren
The metabolic syndrome in HIV.
Best practice & research. Clinical endocrinology & metabolism 2011;25(3):479-86.
2011: Linda Wittkop; Andrea Antinori; Hannah Castro; Geneviève Chêne; Bonaventura Clotet; Céline Colin; Alessandro Cozzi-Lepri; Andrea de Luca; Frank de Wolf; David Dunn; Federico García; Huldrych F Günthard; Ali Judd; Jesper Kjaer; Claudia Kücherer; Jens D Lundgren; Bernard Masquelier; Niels Obel; Roger Paredes; Andrew Phillips; Deenan Pillay; Kholoud Porter; Anton Pozniak; Christoph Stephan; Rodolphe Thiébaut; Carlo Torti; Ard I van Sighem; Viktor von Wyl
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.
The Lancet infectious diseases 2011;11(5):363-71.
2011: Justyna D Kowalska; Amanda Mocroft; bruno ledergerber; Eric Florence; Matti Ristola; Josip Begovac; Helen Sambatakou; Court Pedersen; Jens D Lundgren; Ole Kirk
A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study.
HIV clinical trials 2011;12(2):109-17.
2011: Zoe Fox; Anders Karlsson; Jesper Kjaer; Gitte Kronborg; Jens D Lundgren; Andrew N Phillips; Bonaventura Clotet; Alessandro Cozzi-Lepri; Antonella d'Arminio Monforte
Predictors of having a resistance test following confirmed virological failure of combination antiretroviral therapy: data from EuroSIDA.
Antiviral therapy 2011;16(5):781-5.
2011: Amanda Mocroft; Jacqueline Neuhaus; Adrian Palfreeman; Andrew N Phillips; Giota Touloumi; Michael J Vjecha; Stephane De Wit; Zoe Fox; Sally Hodder; Alan R Lifson; Jens D Lundgren
Haemoglobin and anaemia in the SMART study.
Antiviral therapy 2011;16(3):329-37.
2010: Jens D Lundgren; Andrew N Phillips
Rescue of severely immunocompromised HIV-positive persons.
The Journal of infectious diseases 2010;202(10):1467-9.
2010: Joanne Reekie; Csaba Kosa; Frederik Engsig; Antonella d'Arminio Monforte; Alicja Wiercinska-Drapalo; Pere Domingo; Francisco Antunes; Nathan Clumeck; Ole Kirk; Jens D Lundgren; Amanda Mocroft
Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies.
Cancer 2010;116(22):5306-15.
2010: Nina Friis-Møller; Rodolphe Thiébaut; Peter Reiss; Rainer Weber; Antonella d'Arminio Monforte; Stephane De Wit; Wafaa M El-Sadr; Eric Fontas; Signe Worm; Ole Kirk; Andrew Phillips; Caroline A Sabin; Jens D Lundgren; Matthew G Law
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2010;17(5):491-501.
2010: J Reekie; Amanda Mocroft; bruno ledergerber; Marek Beniowski; Bonaventura Clotet; J van Lunzen; Antonio Chiesi; Christian Pradier; L Machala; Jens D Lundgren
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.
HIV medicine 2010;11(7):469-78.
2010: Amanda Mocroft; Ole Kirk; Peter Reiss; Stephane De Wit; Dalibor Sedlacek; Marek Beniowski; Jose Gatell; Andrew N Phillips; bruno ledergerber; Jens D Lundgren
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
AIDS (London, England) 2010;24(11):1667-78.
2010: J D Kowalska; Ole Kirk; Amanda Mocroft; L Høj; Nina Friis-Møller; Peter Reiss; I Weller; Jens D Lundgren
Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.
HIV medicine 2010;11(3):200-8.
2010: Amanda Mocroft; Andrew N Phillips; bruno ledergerber; Colette Smith; Johannes R Bogner; Karine Lacombe; Alicje Wiercinska-Drapalo; Peter Reiss; Ole Kirk; Jens D Lundgren
Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapy.
Antiviral therapy 2010;15(4):563-70.
2009: Daria Podlekareva; Amanda Mocroft; Frank A Post; Vija Riekstina; Jose M Miro; Hansjakob Furrer; Mathias Bruyand; Alexander Panteleev; Aza G Rakhmanova; Enrico Girardi; Marcello H Losso; Javier J Toibaro; Joan Caylá; Rob F Miller; Niels Obel; Alena Skrahina; Nelly Chentsova; Jens D Lundgren; Ole Kirk
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina.
AIDS (London, England) 2009;23(18):2485-95.
2009: Alison J Rodger; Zoe Fox; Jens D Lundgren; Lewis H Kuller; Christoph Boesecke; Daniela Gey; Athanassios Skoutelis; Matthew Bidwell Goetz; Andrew N Phillips
Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.
The Journal of infectious diseases 2009;200(6):973-83.
2009: Alessandro Cozzi-Lepri; Andrew N Phillips; Javier Martinez-Picado; Antonella d'Arminio Monforte; Christine Katlama; Ann-Brit Eg Hansen; Andrzej Horban; Johann Bruun; Bonaventura Clotet; Jens D Lundgren
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.
The Journal of infectious diseases 2009;200(5):687-97.
2009: Andrew N Phillips; Charles Gilks; Jens D Lundgren
Cost-effectiveness of strategies for monitoring the response to antiretroviral therapy in resource-limited settings.
Archives of internal medicine 2009;169(9):904; author reply 904-5.
2009: Lars Peters; Amanda Mocroft; Vincent Soriano; Jürgen K Rockstroh; Marcelo Losso; Laure Valerio; Pauls Aldins; Peter Reiss; bruno ledergerber; Jens D Lundgren
Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression.
Journal of acquired immune deficiency syndromes (1999) 2009;50(5):457-63.
2009: Jan Gerstoft; Lars Mathiesen; Jens D Lundgren; Henrik I Nielsen; Court Pedersen; Niels Obel; Alex Laursen
[Risk of virus transmission from well-treated patients with HIV?].
Ugeskrift for laeger 2009;171(13):1085.
2009: Ole Kirk; Jan Gerstoft; Jens D Lundgren; Niels Obel
[Major breakthroughs in the medical treatment].
Ugeskrift for laeger 2009;171(10):787-9.
2009: Signe W Worm; Stephane De Wit; Rainer Weber; Caroline A Sabin; Peter Reiss; Wafaa M El-Sadr; Antonella d'Arminio Monforte; Ole Kirk; Eric Fontas; Francois Dabis; Matthew G Law; Jens D Lundgren; Nina Friis-Møller
Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).
Circulation 2009;119(6):805-11.
2009: Matthijs van Luin; Wendy P Bannister; Amanda Mocroft; Peter Reiss; Giovanni Di Perri; Gilles Peytavin; José Molto; Anders Karlson; Antonella Castagna; Marek Beniowski; Jens D Lundgren; David Burger
Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.
Antiviral therapy 2009;14(1):75-83.
2008: Joanne Reekie; Amanda Mocroft; Helen Sambatakou; Ladislav Machala; Antonio Chiesi; Jan van Lunzen; Nathan Clumeck; Ole Kirk; Brian Gazzard; Jens D Lundgren
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?
AIDS (London, England) 2008;22(17):2381-90.
2008: Alessandro Cozzi-Lepri; Andrew N Phillips; Bonaventura Clotet; Amanda Mocroft; Lidia Ruiz; Ole Kirk; Adriano Lazzarin; Alicja Wiercinska-Drapalo; Anders Karlsson; Jens D Lundgren
Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
AIDS (London, England) 2008;22(16):2187-98.
2008: Antonella d'Arminio Monforte; Donald Abrams; Christian Pradier; Rainer Weber; Peter Reiss; Fabrice Bonnet; Ole Kirk; Matthew Law; Stephane De Wit; Nina Friis-Møller; Andrew N Phillips; Caroline A Sabin; Jens D Lundgren
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
AIDS (London, England) 2008;22(16):2143-53.
2008: Jesper Kjaer; L Høj; Zoe Fox; Jens D Lundgren
Prediction of phenotypic susceptibility to antiretroviral drugs using physiochemical properties of the primary enzymatic structure combined with artificial neural networks.
HIV medicine 2008;9(8):642-52.
2008: Daria Podlekareva; Wendy Bannister; Amanda Mocroft; Ludmila Abrosimova; Igor Karpov; Jens D Lundgren; Ole Kirk
The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results.
Central European journal of public health 2008;16(3):99-105.
2008: Wendy P Bannister; Alessandro Cozzi-Lepri; Bonaventura Clotet; Amanda Mocroft; Jesper Kjaer; Peter Reiss; Viktor von Wyl; Adriano Lazzarin; Christine Katlama; Andrew N Phillips; Lidia Ruiz; Jens D Lundgren
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.
Journal of acquired immune deficiency syndromes (1999) 2008;48(3):324-33.
2008: Amanda Mocroft; Ole Kirk; P Aldins; A Chies; Anders Blaxhult; N Chentsova; N Vetter; François Dabis; José M Gatell; Jens D Lundgren
Loss to follow-up in an international, multicentre observational study.
HIV medicine 2008;9(5):261-9.
2008: Caroline A Sabin; Signe W Worm; Rainer Weber; Peter Reiss; Wafaa M El-Sadr; Francois Dabis; Stephane De Wit; Matthew Law; Antonella d'Arminio Monforte; Nina Friis-Møller; Ole Kirk; Christian Pradier; Ian Weller; Andrew N Phillips; Jens D Lundgren
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.
Lancet 2008;371(9622):1417-26.
2008: Jens D Lundgren; Abdel Babiker; Wafaa M El-Sadr; Sean Emery; Birgit Grund; James D Neaton; Jacquie Neuhaus; Andrew N Phillips
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.
The Journal of infectious diseases 2008;197(8):1145-55.
2008: Wendy P Bannister; Lidia Ruiz; Alessandro Cozzi-Lepri; Amanda Mocroft; Ole Kirk; Schlomo Staszewski; Clive Loveday; Anders Karlsson; Antonella d'Arminio Monforte; Bonaventura Clotet; Jens D Lundgren
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA.
AIDS (London, England) 2008;22(3):367-76.
2008: Christian T Brandt; David Holm; Matthew Liptrot; Christian Ostergaard; Jens D Lundgren; Niels Frimodt-Møller; Ian C Skovsted; Ian J Rowland
Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis.
The Journal of infectious diseases 2008;197(2):235-44.
2008: Colette J Smith; Christian Holkmann Olsen; Amanda Mocroft; Jean-Paul Viard; Schlomo Staszewski; George Panos; Therese Staub; Anders Blaxhult; Norbert Vetter; Jens D Lundgren
The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study.
AIDS (London, England) 2008;22(1):47-56.
2008: Wendy P Bannister; Nina Friis-Møller; Amanda Mocroft; Jean-Paul Viard; Jan van Lunzen; Ole Kirk; Panagiotis Gargalianos; Dénes Bánhegyi; Antonio Chiesi; Jens D Lundgren
Incidence of abacavir hypersensitivity reactions in euroSIDA.
Antiviral therapy 2008;13(5):687-96.
2008: Andrew N Phillips; Andrew Carr; Jacquie Neuhaus; Fehmida Visnegarwala; Ronald Prineas; William Burman; Ian Williams; FJ Drummond; Daniel Duprez; Waldo H Belloso; Frank-Detlef Goebel; Birgit Grund; Angelos Hatzakis; Jose Vera; Jens D Lundgren
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.
Antiviral therapy 2008;13(2):177-87.
2008: Amanda Mocroft; Andrzej Horban; Bonaventura Clotet; Antonella d'Arminio Monforte; J R Bogner; P Aldins; T Staub; Francisco Antunes; Christine Katlama; Jens D Lundgren
Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999.
HIV medicine 2008;9(1):41-6.
2008: Christian T Brandt; Helle Simonsen; Matthew Liptrot; Lise V Søgaard; Jens D Lundgren; Christian Ostergaard; Niels Frimodt-Møller; Ian J Rowland
In vivo study of experimental pneumococcal meningitis using magnetic resonance imaging.
BMC medical imaging 2008;8():1.
2007: Ulrik S Justesen; Zoe Fox; Court Pedersen; Pedro Cahn; Jan Gerstoft; Nathan Clumeck; Marcelo H Losso; Barry Peters; Niels Obel; Antonella Castagna; Ulrik B Dragsted; Jens D Lundgren
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials.
Basic & clinical pharmacology & toxicology 2007;101(5):339-44.
2007: Francesca Ceccherini-Silberstein; Alessandro Cozzi-Lepri; Lidia Ruiz; Amanda Mocroft; Andrew N Phillips; Christian Holkmann Olsen; José M Gatell; Huldrych F Gunthard; Peter Reiss; Carlo Federico Perno; Bonaventura Clotet; Jens D Lundgren
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients.
The Journal of infectious diseases 2007;196(8):1180-90.
2007: Zoe Fox; Anna Maria Geretti; Jesper Kjaer; Ulrik B Dragsted; Andrew N Phillips; Jan Gerstoft; Schlomo Staszewski; Bonaventura Clotet; Viktor von Wyl; Jens D Lundgren
The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors.
AIDS (London, England) 2007;21(15):2033-42.
2007: Amanda Mocroft; bruno ledergerber; Kai Zilmer; Ole Kirk; Bernard Hirschel; Jean-Paul Viard; Peter Reiss; Patrick Francioli; Adriano Lazzarin; Ladislav Machala; Andrew N Phillips; Jens D Lundgren
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
AIDS (London, England) 2007;21(14):1867-75.
2007: Amanda Mocroft; Andrew N Phillips; José M Gatell; bruno ledergerber; Martin Fisher; Nathan Clumeck; Marcelo H Losso; Adriano Lazzarin; G Fatkenheuer; Jens D Lundgren
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
Lancet 2007;370(9585):407-13.
2007: Amanda Mocroft; Ole Kirk; José M Gatell; Peter Reiss; Panagiotis Gargalianos; Kai Zilmer; Marek Beniowski; Jean-Paul Viard; Schlomo Staszewski; Jens D Lundgren
Chronic renal failure among HIV-1-infected patients.
AIDS (London, England) 2007;21(9):1119-27.
2007: Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa M El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren
Class of antiretroviral drugs and the risk of myocardial infarction.
The New England journal of medicine 2007;356(17):1723-35.
2007: Alessandro Cozzi-Lepri; Andrew N Phillips; Lidia Ruiz; Bonaventura Clotet; Clive Loveday; Jesper Kjaer; Helene Mens; Nathan Clumeck; Ludmila Viksna; Francisco Antunes; Ladislav Machala; Jens D Lundgren
Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.
AIDS (London, England) 2007;21(6):721-32.
2007: Zoe Fox; Francisco Antunes; Rick Davey; Brian Gazzard; Nancy Klimas; Ann Labriola; Marcelo H Losso; James D Neaton; Andrew N Phillips; Kiat Ruxrungtham; Schlomo Staszewski; Laurence Weiss; Jens D Lundgren
Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells/microL who were assigned to 7.5 MIU interleukin-2.
HIV medicine 2007;8(2):112-23.
2007: Andrew N Phillips; Brian G Gazzard; Nathan Clumeck; Marcelo H Losso; Jens D Lundgren
When should antiretroviral therapy for HIV be started?
BMJ (Clinical research ed.) 2007;334(7584):76-8.
2007: Amanda Mocroft; Schlomo Staszewski; Rainer Weber; José M Gatell; Jürgen Rockstroh; Jacek Gasiorowski; George Panos; Antonella d'Arminio Monforte; Aza Rakhmanova; Andrew N Phillips; Jens D Lundgren
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.
Antiviral therapy 2007;12(3):325-33.
2007: Hans Henrik Larsen; Marie-Louise von Linstow; Bettina Lundgren; Birthe Høgh; Henrik Westh; Jens D Lundgren
Primary pneumocystis infection in infants hospitalized with acute respiratory tract infection.
Emerging infectious diseases 2007;13(1):66-72.
2006: Christian T Brandt; Niels Frimodt-Møller; Jens D Lundgren; Michael Pedersen; Ian C Skovsted; Ian J Rowland; Christian Østergaard
Evaluation of anti-pneumococcal capsular antibodies as adjunctive therapy in experimental pneumococcal meningitis.
The Journal of antimicrobial chemotherapy 2006;58(6):1291-4.
2006: Wafaa M El-Sadr; Jens D Lundgren; James D Neaton; Fred M Gordin; D Abrams; Roberto C Arduino; A Babiker; William Burman; Nathan Clumeck; C J Cohen; D Cohn; D Cooper; Janet Darbyshire; Sean Emery; G Fätkenheuer; B Gazzard; B Grund; J Hoy; K Klingman; Marcelo H Losso; Norman Markowitz; J Neuhaus; A Phillips; C Rappoport
CD4+ count-guided interruption of antiretroviral treatment.
The New England journal of medicine 2006;355(22):2283-96.
2006: Andrew N Phillips; Cal Cohen; Jens D Lundgren
Issues in the design of trials comparing management strategies for heavily pretreated patients.
Current opinion in HIV and AIDS 2006;1(6):476-81.
2006: Daria Podlekareva; Amanda Mocroft; Ulrik B Dragsted; bruno ledergerber; Marek Beniowski; Adriano Lazzarin; Jonathan Weber; Nathan Clumeck; Norbert Vetter; Andrew Phillips; Jens D Lundgren
Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study.
The Journal of infectious diseases 2006;194(5):633-41.
2006: Rainer Weber; Caroline A Sabin; Nina Friis-Møller; Peter Reiss; Wafaa M El-Sadr; Ole Kirk; François Dabis; Matthew G Law; Christian Pradier; Stephane De Wit; Börje Akerlund; Gonzalo Calvo; Antonella d'Arminio Monforte; Martin Rickenbach; bruno ledergerber; Andrew N Phillips; Jens D Lundgren
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.
Archives of internal medicine 2006;166(15):1632-41.
2006: Christian T Brandt; Per Cayé-Thomasen; Søren Peter Lund; L Worsøe; Christian Ostergaard; Niels Frimodt-Møller; Frank Espersen; Jens Thomsen; Jens D Lundgren
Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes.
Neurobiology of disease 2006;23(2):300-11.
2006: Wendy P Bannister; Ole Kirk; José M Gatell; Brygida Knysz; Jean-Paul Viard; Helene Mens; Antonella d'Arminio Monforte; Andrew N Phillips; Amanda Mocroft; Jens D Lundgren
Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe.
Journal of acquired immune deficiency syndromes (1999) 2006;42(2):229-37.
2006: Amanda Mocroft; Andrew N Phillips; bruno ledergerber; Christine Katlama; Antonio Chiesi; Frank-Detlef Goebel; Brygida Knysz; Francisco Antunes; Peter Reiss; Jens D Lundgren
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.
AIDS (London, England) 2006;20(8):1141-50.
2006: Matthew G Law; Nina Friis-Møller; Wafaa M El-Sadr; Rainer Weber; Peter Reiss; Antonella d'Arminio Monforte; Rodolphe Thiébaut; Linda Morfeldt; Stephane De Wit; Christian Pradier; Gonzalo Calvo; Ole Kirk; Caroline A Sabin; Andrew N Phillips; Jens D Lundgren
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.
HIV medicine 2006;7(4):218-30.
2006: Zoe Fox; Ulrik B Dragsted; Jan Gerstoft; Andrew N Phillips; Jesper Kjaer; Lars Mathiesen; Mike Youle; Christine Katlama; Andrew Hill; Johan Bruun; Nathan Clumeck; Pierre Dellamonica; Jens D Lundgren
A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial.
Antiviral therapy 2006;11(6):761-70.
2006: Amanda Mocroft; Jürgen Rockstroh; Vincent Soriano; Ole Kirk; Jean-Paul Viard; Saulius Caplinskas; Jacek Gasiorowski; Antonio Chiesi; Andrew N Phillips; Jens D Lundgren
Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C.
Scandinavian journal of infectious diseases 2006;38(11-12):1092-7.
2006: Amanda Mocroft; J Neaton; J Bebchuk; S Staszewski; Francisco Antunes; Brygida Knysz; M Law; Andrew N Phillips; Jens D Lundgren
The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era.
Clinical trials (London, England) 2006;3(2):119-32.
2006: Christian Østergaard; Terence O'Reilly; Christian Brandt; Niels Frimodt-Møller; Jens D Lundgren
Influence of the blood bacterial load on the meningeal inflammatory response in Streptococcus pneumoniae meningitis.
BMC infectious diseases 2006;6():78.
2005: Amanda Mocroft; Vincent Soriano; Jürgen Rockstroh; Peter Reiss; Ole Kirk; Stephane de Wit; José M Gatell; Bonaventura Clotet; Andrew N Phillips; Jens D Lundgren
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
AIDS (London, England) 2005;19(18):2117-25.
2005: Hans L Tillmann; Thorsten Kaiser; Zoe Fox; Schlomo Staszewski; Francesco Antunes; Antonella d'Arminio Monforte; Pietro Vernazza; Andrew Hill; Ulrik B Dragsted; Jens D Lundgren
Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial.
Journal of acquired immune deficiency syndromes (1999) 2005;40(3):378-80.
2005: Amanda Mocroft; Andrew N Phillips; V Soriano; Jürgen Rockstroh; Anders Blaxhult; C Katlama; A Boron-Kaczmarska; Ludmila Viksna; Ole Kirk; Jens D Lundgren
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection.
AIDS research and human retroviruses 2005;21(9):743-52.
2005: Christian T Brandt; Jens D Lundgren; Niels Frimodt-Møller; Thomas Christensen; Thomas Benfield; Frank Espersen; David M Hougaard; Christian Ostergaard
Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis.
Journal of neuroimmunology 2005;166(1-2):126-31.
2005: Amanda Mocroft; Andrew N Phillips; V Soriano; Jürgen Rockstroh; Anders Blaxhult; C Katlama; A Boron-Kaczmarska; Ludmila Viksna; Ole Kirk; Jens D Lundgren
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection.
AIDS research and human retroviruses 2005;21(6):527-36.
2005: Pernille Ravn; Martin E Munk; Ase B Andersen; Bettina Lundgren; Jens D Lundgren; Lars N Nielsen; Axel Kok-Jensen; Peter Andersen; Karin Weldingh
Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis.
Clinical and diagnostic laboratory immunology 2005;12(4):491-6.
2005: Christian Holkmann Olsen; José M Gatell; bruno ledergerber; Christine Katlama; Nina Friis-Møller; Jonathan Weber; Andrzej Horban; Schlomo Staszewski; Jens D Lundgren; Andrew N Phillips
Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen.
AIDS (London, England) 2005;19(3):319-30.
2005: Rodolphe Thiébaut; Wafaa M El-Sadr; Nina Friis-Møller; Martin Rickenbach; Peter Reiss; Antonella d'Arminio Monforte; Linda Morfeldt; Eric Fontas; Ole Kirk; Stephane De Wit; Gonzalo Calvo; Matthew G Law; François Dabis; Caroline A Sabin; Jens D Lundgren
Predictors of hypertension and changes of blood pressure in HIV-infected patients.
Antiviral therapy 2005;10(7):811-23.
2005: Alessandro Cozzi-Lepri; Lidia Ruiz; Clive Loveday; Andrew N Phillips; Bonaventura Clotet; Peter Reiss; bruno ledergerber; Christian Holkmann; Schlomo Staszewski; Jens D Lundgren
Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapy.
Antiviral therapy 2005;10(7):791-802.
2005: Amanda Mocroft; Jürgen Rockstroh; Vincent Soriano; bruno ledergerber; Ole Kirk; Elena Vinogradova; Peter Reiss; Christine Katlama; Andrew N Phillips; Jens D Lundgren
Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?
Antiviral therapy 2005;10(7):779-90.
2005: Ulrik B Dragsted; Jan Gerstoft; Mike Youle; Zoe Fox; Marcelo H Losso; Jorge Benetucci; Dushyantha Jayaweera; Armin Rieger; Johan Bruun; Antonella Castagna; Brian Gazzard; Sharon Walmsley; Andrew Hill; Jens D Lundgren
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial.
Antiviral therapy 2005;10(6):735-43.
2004: Amanda Mocroft; bruno ledergerber; Jean-Paul Viard; Schlomo Staszewski; M Murphy; Antonio Chiesi; Andrzej Horban; Ann-Brit Eg Hansen; Andrew N Phillips; Jens D Lundgren
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group.
The Journal of infectious diseases 2004;190(11):1947-56.
2004: Amanda Mocroft; Antonella d'Arminio Monforte; Ole Kirk; Margaret A Johnson; N Friis-Moller; D Banhegyi; Anders Blaxhult; F Mulcahy; José M Gatell; Jens D Lundgren
Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study.
HIV medicine 2004;5(6):437-47.
2004: Cecilia Cabrera; Alessandro Cozzi-Lepri; Andrew N Phillips; Clive Loveday; Ole Kirk; Mounir Ait-Khaled; Peter Reiss; Jesper Kjaer; bruno ledergerber; Jens D Lundgren; Bonaventura Clotet; Lidia Ruiz
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.
Antiviral therapy 2004;9(5):787-800.
2004: A d'Arminio; Caroline A Sabin; Andrew N Phillips; Peter Reiss; Rainer Weber; Ole Kirk; Wafaa M El-Sadr; Stephane De Wit; Silvia Mateu; K Petoumenos; François Dabis; Christian Pradier; Linda Morfeldt; Jens D Lundgren; Nina Friis-Møller
Cardio- and cerebrovascular events in HIV-infected persons.
AIDS (London, England) 2004;18(13):1811-7.
2004: Andrew N Phillips; bruno ledergerber; Andrzej Horban; Peter Reiss; Antonio Chiesi; Ole Kirk; Fiona Mulchany; Martin Fisher; Ladislav Machala; Jens D Lundgren
Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression.
AIDS (London, England) 2004;18(13):1795-804.
2004: Birgit T Røge; Toke S Barfod; Ole Kirk; Terese L Katzenstein; Niels Obel; Henrik Nielsen; Court Pedersen; Lars Mathiesen; Jens D Lundgren; Jan Gerstoft
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study.
HIV medicine 2004;5(5):344-51.
2004: Christian T Brandt; Jens D Lundgren; Søren Peter Lund; Niels Frimodt-Møller; Thomas Christensen; Thomas Benfield; Frank Espersen; David M Hougaard; Christian Østergaard
Attenuation of the bacterial load in blood by pretreatment with granulocyte-colony-stimulating factor protects rats from fatal outcome and brain damage during Streptococcus pneumoniae meningitis.
Infection and immunity 2004;72(8):4647-53.
2004: bruno ledergerber; Jens D Lundgren; A Sarah Walker; Caroline Sabin; Amy Justice; Peter Reiss; Cristina Mussini; Ferdinand Wit; Antonella d'Arminio Monforte; Rainer Weber; Gregory Fusco; Schlomo Staszewski; Matthew Law; Hogg Robert; Fiona Lampe; M John Gill; Francesco Castelli; Andrew N Phillips
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
Lancet 2004;364(9428):51-62.
2004: Ulrik B Dragsted; Amanda Mocroft; STEFANO VELLA; Jean-Paul Viard; Ann-Brit Eg Hansen; George Panos; Danielle Mercey; Ladislav Machala; Andrzej Horban; Jens D Lundgren
Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study.
The Journal of infectious diseases 2004;190(1):148-55.
2004: Amanda Mocroft; Jens D Lundgren
Starting highly active antiretroviral therapy: why, when and response to HAART.
The Journal of antimicrobial chemotherapy 2004;54(1):10-3.
2004: Amanda Mocroft; Ole Kirk; Nathan Clumeck; Panaglotis Gargalianos-Kakolyris; Hanna Trocha; Nelly Chentsova; Francisco Antunes; Hans-Jürgen Stellbrink; Andrew N Phillips; Jens D Lundgren
The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
Cancer 2004;100(12):2644-54.
2004: Sofie Mathiesen; Birgit T Roge; Nina Weis; Jens D Lundgren; Niels Obel; Jan Gerstoft
Foscarnet used in salvage therapy of HIV-1 patients harbouring multiple nucleotide excision mutations.
AIDS (London, England) 2004;18(7):1076-8.
2004: Eric Fontas; F van Leth; C A Sabin; Nina Friis-Møller; Martin Rickenbach; Antonella d'Arminio Monforte; Ole Kirk; M Dupon; Linda Morfeldt; Silvia Mateu; K Petoumenos; W El-Sadr; Stephane De Wit; Jens D Lundgren; Christian Pradier; P Reiss
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
The Journal of infectious diseases 2004;189(6):1056-74.
2004: Christian Ostergaard; Thomas Benfield; Jens D Lundgren; Jesper Eugen-Olsen
Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcome.
Scandinavian journal of infectious diseases 2004;36(1):14-9.
2003: Ole Kirk; Jens D Lundgren; Court Pedersen; Lars Mathiesen; Henrik Nielsen; Terese L Katzenstein; Niels Obel; Jan Gerstoft
A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.
Antiviral therapy 2003;8(6):595-602.
2003: Nina Friis-Møller; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa M El-Sadr; Peter Reiss; Rodolphe Thiébaut; Linda Morfeldt; Stephane De Wit; Christian Pradier; Gonzalo Calvo; Matthew G Law; Ole Kirk; Andrew N Phillips; Jens D Lundgren
Combination antiretroviral therapy and the risk of myocardial infarction.
The New England journal of medicine 2003;349(21):1993-2003.
2003: Jan Gerstoft; Ole Kirk; Niels Obel; Court Pedersen; Lars Mathiesen; Henrik Nielsen; Terese L Katzenstein; Jens D Lundgren
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.
AIDS (London, England) 2003;17(14):2045-52.
2003: Ulrik B Dragsted; Jan Gerstoft; Court Pedersen; Barry Peters; Adriana Duran; Niels Obel; Antonella Castagna; Pedro Cahn; Nathan Clumeck; Johan Bruun; Jorge Benetucci; Andrew Hill; Isabel Cassetti; Pietro Vernazza; Mike Youle; Zoe Fox; Jens D Lundgren
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.
The Journal of infectious diseases 2003;188(5):635-42.
2003: Amanda Mocroft; Lidia Ruiz; Peter Reiss; bruno ledergerber; Christine Katlama; Adriano Lazzarin; Frank-Detlef Goebel; Andrew N Phillips; Bonaventura Clotet; Jens D Lundgren
Virological rebound after suppression on highly active antiretroviral therapy.
AIDS (London, England) 2003;17(12):1741-51.
2003: Amanda Mocroft; bruno ledergerber; Christine Katlama; Ole Kirk; Peter Reiss; Antonella d'Arminio Monforte; Brygida Knysz; M Dietrich; Andrew N Phillips; Jens D Lundgren
Decline in the AIDS and death rates in the EuroSIDA study: an observational study.
Lancet 2003;362(9377):22-9.
2003: Nina Friis-Møller; Rainer Weber; Peter Reiss; Rodolphe Thiébaut; Ole Kirk; Antonella d'Arminio Monforte; Christian Pradier; Linda Morfeldt; Silvia Mateu; Matthew Law; Wafaa M El-Sadr; Stephane De Wit; Caroline A Sabin; Andrew N Phillips; Jens D Lundgren
Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
AIDS (London, England) 2003;17(8):1179-93.
2003: M Law; Nina Friis-Møller; Rainer Weber; Peter Reiss; R Thiebaut; Ole Kirk; Antonella d'Arminio Monforte; Christian Pradier; Linda Morfeldt; Gonzalo Calvo; Wafaa M El-Sadr; Stephane De Wit; Caroline A Sabin; Jens D Lundgren
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.
HIV medicine 2003;4(1):1-10.
2002: Amanda Mocroft; R Brettle; Ole Kirk; Anders Blaxhult; J M Parkin; Francisco Antunes; Patrick Francioli; Antonella d'Arminio Monforte; Zoe Fox; Jens D Lundgren
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study.
AIDS (London, England) 2002;16(12):1663-71.
2002: Christian Østergaard; Julia S Johansen; Thomas Benfield; Paul A Price; Jens D Lundgren
YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis.
Clinical and diagnostic laboratory immunology 2002;9(3):598-604.
2002: Amanda Mocroft; Andrew N Phillips; N Friis-Møller; Robert Colebunders; A M Johnson; Bernard Hirschel; T Saint-Marc; T Staub; Bonaventura Clotet; Jens D Lundgren
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study.
Antiviral therapy 2002;7(1):21-30.
2001: Andrew N Phillips; Christian Pradier; Adriano Lazzarin; Bonaventura Clotet; Frank-Detlef Goebel; P Hermans; Francisco Antunes; bruno ledergerber; Ole Kirk; Jens D Lundgren
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients.
AIDS (London, England) 2001;15(18):2385-95.
2001: Jannik Helweg-Larsen; Bettina Lundgren; Jens D Lundgren
Heterogeneity and compartmentalization of Pneumocystis carinii f. sp. hominis genotypes in autopsy lungs.
Journal of clinical microbiology 2001;39(10):3789-92.
2001: Ole Kirk; Amanda Mocroft; C Pradier; JN Bruun; R Hemmer; Bonaventura Clotet; Veronica Miller; Jean-Paul Viard; Andrew N Phillips; Jens D Lundgren
Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir.
AIDS (London, England) 2001;15(8):999-1008.
2001: Ole Kirk; J Glenthøj; Ulrik B Dragsted; Jannik Helweg-Larsen; T M Aru; Thomas Benfield; K Jensen; J Vestbo; Jens D Lundgren
Penicillin as empirical therapy for patients hospitalised with community acquired pneumonia at a Danish hospital.
Danish medical bulletin 2001;48(2):84-8.
2001: Jean-Paul Viard; Amanda Mocroft; Antonio Chiesi; Ole Kirk; Birgit T Røge; George Panos; N Vetter; JN Bruun; M Johnson; Jens D Lundgren
Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study.
The Journal of infectious diseases 2001;183(8):1290-4.
2001: Jannik Helweg-Larsen; C H Lee; S Jin; J Y Hsueh; Thomas Benfield; J Hansen; Jens D Lundgren; Bettina Lundgren
Clinical correlation of variations in the internal transcribed spacer regions of rRNA genes in Pneumocystis carinii f.sp. hominis.
AIDS (London, England) 2001;15(4):451-9.
2001: Thomas Benfield; Jannik Helweg-Larsen; D Bang; J Junge; Jens D Lundgren
Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia.
Chest 2001;119(3):844-51.
2001: Amanda Mocroft; Andrew N Phillips; Veronica Miller; José M Gatell; Jan van Lunzen; J M Parkin; R Weber; B Roge; Adriano Lazzarin; Jens D Lundgren
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study.
AIDS (London, England) 2001;15(2):201-9.
2001: bruno ledergerber; A Mocroft; Peter Reiss; Hansjakob Furrer; Ole Kirk; M Bickel; Caterina Uberti-Foppa; Christian Pradier; Antonella d'Arminio Monforte; M M Schneider; Jens D Lundgren
Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
The New England journal of medicine 2001;344(3):168-74.
2001: Ole Kirk; Jan Gerstoft; Court Pedersen; Henrik Nielsen; Niels Obel; Terese L Katzenstein; Lars Mathiesen; Jens D Lundgren
Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort.
HIV medicine 2001;2(1):43-51.
2000: Christian Ostergaard; Runa Vavia Yieng-Kow; C G Larsen; N Mukaida; K Matsushima; Thomas Benfield; Niels Frimodt-Møller; Frank Espersen; A Kharazmi; Jens D Lundgren
Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally.
Clinical and experimental immunology 2000;122(2):207-11.
2000: Terese L Katzenstein; Ole Kirk; Court Pedersen; Jens D Lundgren; Henrik Nielsen; Niels Obel; Claus Nielsen; Lars Mathiesen; Jan Gerstoft
The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 2000;182(3):744-50.
2000: Anders Blaxhult; Ole Kirk; C Pedersen; M Dietrich; S E Barton; José M Gatell; F Mulcahy; Bernard Hirschel; Amanda Mocroft; Jens D Lundgren
Regional differences in presentation of AIDS in Europe.
Epidemiology and infection 2000;125(1):143-51.
2000: Amanda Mocroft; Christine Katlama; Anne M Johnson; C Pradier; Francisco Antunes; F Mulcahy; Antonio Chiesi; Andrew N Phillips; Ole Kirk; Jens D Lundgren
AIDS across Europe, 1994-98: the EuroSIDA study.
Lancet 2000;356(9226):291-6.
2000: Amanda Mocroft; Veronica Miller; Antonio Chiesi; Anders Blaxhult; Christine Katlama; Bonaventura Clotet; S Barton; Jens D Lundgren
Virological failure among patients on HAART from across Europe: results from the EuroSIDA study.
Antiviral therapy 2000;5(2):107-12.
2000: Christian Ostergaard; Runa Vavia Yieng-Kow; Thomas Benfield; Niels Frimodt-Møller; Frank Espersen; Jens D Lundgren
Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits.
Infection and immunity 2000;68(6):3153-7.
1999: Amanda Mocroft; Sara Madge; Anne M Johnson; Adriano Lazzarin; Nathan Clumeck; Frank-Detlef Goebel; Jean-Paul Viard; José M Gatell; Anders Blaxhult; Jens D Lundgren
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival.
Journal of acquired immune deficiency syndromes (1999) 1999;22(4):369-78.
1999: Antonio Chiesi; Amanda Mocroft; L G Dally; Veronica Miller; Christine Katlama; bruno ledergerber; C Pedersen; Andrew N Phillips; Romano Arcieri; Jens D Lundgren
Regional survival differences across Europe in HIV-positive people: the EuroSIDA study.
AIDS (London, England) 1999;13(16):2281-8.
1999: Andrew N Phillips; Sophie Grabar; Jean-Michel Tassie; Dominique Costagliola; Jens D Lundgren; Matthias Egger
Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups.
AIDS (London, England) 1999;13(15):2075-82.
1999: Jannik Helweg-Larsen; Thomas Benfield; Jesper Eugen-Olsen; Jens D Lundgren; Bettina Lundgren
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
Lancet 1999;354(9187):1347-51.
1999: Anders Blaxhult; Amanda Mocroft; A Phillips; Jan van Lunzen; Z Bentwich; G Stergiou; Robert Colebunders; T L Benfield; F Mulcahy; Jens D Lundgren
Does European or non-European origin influence health care and prognosis for HIV patients in Europe? The EuroSIDA Study Group.
HIV medicine 1999;1(1):2-9.
1999: Ole Kirk; Jens D Lundgren; Court Pedersen; Henrik Nielsen; Jan Gerstoft
Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?
AIDS (London, England) 1999;13(13):1647-51.
1999: Christian Ostergaard; Thomas Benfield; B Gesser; A Kharazmi; Niels Frimodt-Møller; Frank Espersen; Jens D Lundgren
Pretreatment with granulocyte colony-stimulating factor attenuates the inflammatory response but not the bacterial load in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits.
Infection and immunity 1999;67(7):3430-6.
1999: Amanda Mocroft; Ole Kirk; SE Barton; M Dietrich; R Proenca; Robert Colebunders; Christian Pradier; A dArminio Monforte; bruno ledergerber; Jens D Lundgren
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group.
AIDS (London, England) 1999;13(8):943-50.
1999: Gerrit Jan Weverling; Amanda Mocroft; bruno ledergerber; Ole Kirk; J Gonzáles-Lahoz; A d'Arminio Monforte; R Proenca; Andrew N Phillips; Jens D Lundgren; P Reiss
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.
Lancet 1999;353(9161):1293-8.
1999: Ole Kirk; Terese L Katzenstein; Jan Gerstoft; Lars Mathiesen; Henrik Nielsen; Court Pedersen; Jens D Lundgren
Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial.
AIDS (London, England) 1999;13(1):F9-16.
1999: U B Dragsted; J Bauer; S Poulsen; Dorthe Askgaard; Ase B Andersen; Jens D Lundgren
Epidemiology of tuberculosis in HIV-infected patients in Denmark.
Scandinavian journal of infectious diseases 1999;31(1):57-61.
1998: Amanda Mocroft; STEFANO VELLA; T L Benfield; Antonio Chiesi; Veronica Miller; Panagiotis Gargalianos; Antonella d'Arminio Monforte; Israel Yust; JN Bruun; Andrew N Phillips; Jens D Lundgren
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.
Lancet 1998;352(9142):1725-30.
1998: Thomas Benfield; Jens D Lundgren
The Pneumocystis carinii major surface glycoprotein (MSG): its potential involvement in the pathophysiology of pneumocystosis.
FEMS immunology and medical microbiology 1998;22(1-2):129-34.
1998: Jannik Helweg-Larsen; Jorgen Jensen; Thomas Benfield; U G Svendsen; Jens D Lundgren; Bettina Lundgren
Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples.
Journal of clinical microbiology 1998;36(7):2068-72.
1998: Chao-Hung Lee; Jannik Helweg-Larsen; Xing Tang; S Jin; B Li; Marilyn S Bartlett; JJ Lu; Bettina Lundgren; Jens D Lundgren; M Olsson; Sebastian Lucas; P Roux; Antonietta Cargnel; Chiara Atzori; Olga Matos; James W Smith
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes.
Journal of clinical microbiology 1998;36(3):734-41.
1998: Henrik Nielsen; B Kvinesdal; Thomas Benfield; Jens D Lundgren; Helle Bossen Konradsen
Rapid loss of specific antibodies after pneumococcal vaccination in patients with human immunodeficiency virus-1 infection.
Scandinavian journal of infectious diseases 1998;30(6):597-601.
1997: Michael Burke; Israel Yust; Christine Katlama; Nurith Vardinon; N Clumeck; A J Pinching; bruno ledergerber; J M Gatell; Antonio Chiesi; S E Barton; Jens D Lundgren; C Pedersen
Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(12):876-82.
1997: Thomas Benfield; Bettina Lundgren; Stewart J Levine; G Kronborg; J H Shelhamer; Jens D Lundgren
The major surface glycoprotein of Pneumocystis carinii induces release and gene expression of interleukin-8 and tumor necrosis factor alpha in monocytes.
Infection and immunity 1997;65(11):4790-4.
1997: E Krarup; J Vestbo; Thomas Benfield; Jens D Lundgren
Interleukin-8 and leukotriene B4 in bronchoalveolar lavage fluid from HIV-infected patients with bacterial pneumonia.
Respiratory medicine 1997;91(5):317-21.
1997: Bettina Lundgren; K Elvin; L P Rothman; I Ljungström; C Lidman; Jens D Lundgren
Transmission of Pneumocystis carinii from patients to hospital staff.
Thorax 1997;52(5):422-4.
1997: Thomas Benfield; P Prentø; J Junge; J Vestbo; Jens D Lundgren
Alveolar damage in AIDS-related Pneumocystis carinii pneumonia.
Chest 1997;111(5):1193-9.
1997: K K Hansen; J Vestbo; Thomas Benfield; Jens D Lundgren; Lars Mathiesen
Rapid detection of cytomegalovirus in bronchoalveolar lavage fluid and serum samples by polymerase chain reaction: correlation of virus isolation and clinical outcome for patients with human immunodeficiency virus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(5):878-83.
1997: Thomas Benfield; A Kharazmi; C G Larsen; Jens D Lundgren
Neutrophil chemotactic activity in bronchoalveolar lavage fluid of patients with AIDS-associated Pneumocystis carinii pneumonia.
Scandinavian journal of infectious diseases 1997;29(4):367-71.
1997: Thomas Benfield; KK Dodt; Jens D Lundgren
Human herpes virus-8 DNA in bronchoalveolar lavage samples from patients with AIDS-associated pulmonary Kaposi's sarcoma.
Scandinavian journal of infectious diseases 1997;29(1):13-6.
1996: Bettina Lundgren; I Jungström; L P Rothman; K Elvin; Jens D Lundgren
Antibody responses to Pneumocystis carinii in hospital personal with and without exposure to patients with P. carinii pneumonia.
The Journal of eukaryotic microbiology 1996;43(5):10S.
1996: Bettina Lundgren; T Benfield; Jens D Lundgren
Evaluation of PCR technique for diagnosing Pneumocystis carinii pneumonia in HIV positive patients using oropharyngeal washings.
The Journal of eukaryotic microbiology 1996;43(5):9S.
1996: Thomas Benfield; Jørgen Vestbo; J Junge; TL Nielsen; A M Jensen; Jens D Lundgren
[Prognostic value of interleukin-8 in AIDS-related Pneumocystis carinii pneumonia].
Ugeskrift for laeger 1996;158(11):1513-7.
1995: A M Jensen; Jens D Lundgren; Thomas Benfield; TL Nielsen; Jørgen Vestbo
Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? A note for caution.
Chest 1995;108(2):411-4.
1995: Jens D Lundgren; S E Barton; C Katlama; bruno ledergerber; J González-Lahoz; A J Pinching; R Proenca; R Hemmer; Court Pedersen; Andrew N Phillips
Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome. Multicentre Study Group on AIDS in Europe.
Archives of internal medicine 1995;155(8):822-8.
1995: Thomas Benfield; Jørgen Vestbo; J Junge; TL Nielsen; Anders Bonde Jensen; Jens D Lundgren
Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia.
American journal of respiratory and critical care medicine 1995;151(4):1058-62.
1995: Thomas Benfield; RP van Steenwijk; TL Nielsen; J R Dichter; G Y Lipschik; B N Jensen; J Junge; James H Shelhamer; Jens D Lundgren
Interleukin-8 and eicosanoid production in the lung during moderate to severe Pneumocystis carinii pneumonia in AIDS: a role of interleukin-8 in the pathogenesis of P. carinii pneumonia.
Respiratory medicine 1995;89(4):285-90.
1995: Jens D Lundgren; Court Pedersen; K D Bentsen; Jan Gerstoft; T Seefeldt-Nielsen; TL Nielsen; G F Jensen
[AIDS in Denmark. 2. Survival after the diagnosis of AIDS. Danish Study Group for HIV infection].
Ugeskrift for laeger 1995;157(10):1352-6.
1995: Jens D Lundgren; K D Bentsen; Court Pedersen; Jan Gerstoft; T Seefeldt-Nielsen; TL Nielsen; G F Jensen
[AIDS in Denmark. 1. Opportunistic infections and malignant diseases. Danish Study Group for HIV infection].
Ugeskrift for laeger 1995;157(10):1347-51.
1995: J Skøt; A G Lerche; Hans Jørn J Kolmos; Jens Ole Nielsen; L R Mathiesen; Jens D Lundgren
Pneumocystis carinii in bronchoalveolar lavage and induced sputum: detection with a nested polymerase chain reaction.
Scandinavian journal of infectious diseases 1995;27(4):363-7.
1994: Jens D Lundgren; R D Rieves; Joaquim Mullol; Carolea Logun; James H Shelhamer
The effect of neutrophil protenase enzymes on the release of mucus from feline and human airway cultures.
Respiratory medicine 1994;88(7):511-8.
1994: A M Jensen; Jens D Lundgren; TL Nielsen; Thomas Benfield; Jørgen Vestbo
[Pneumocystis carinii pneumonia in HIV-infected patients examined by bronchoscopy during the period 1989-1991].
Ugeskrift for laeger 1994;156(29):4241-4.
1994: Thomas Benfield; J K Schattenkerk; B Hofmann; B N Jensen; TL Nielsen; Jens D Lundgren
Differential effect on serum neopterin and serum beta 2-microglobulin is induced by treatment in Pneumocystis carinii pneumonia.
The Journal of infectious diseases 1994;169(5):1170-3.
1993: K D Bentsen; TL Nielsen; J K Eaftinck Schattenkerk; B N Jensen; Jens D Lundgren
Serum type III procollagen peptide in patients with Pneumocystis carinii infection. The Copenhagen-Amsterdam PCP-Prednisolone Study Group.
The American review of respiratory disease 1993;148(6 Pt 1):1558-62.
1993: Jørgen Vestbo; TL Nielsen; J Junge; Jens D Lundgren
Amount of Pneumocystis carinii and degree of acute lung inflammation in HIV-associated P carinii pneumonia.
Chest 1993;104(1):109-13.
1993: A Z Gawin; James N Baraniuk; Jens D Lundgren; M Kaliner
Effects of gastrin-releasing peptide and analogues on guinea pig nasal mucosal secretion.
The American journal of physiology 1993;264(4 Pt 1):L345-50.
1993: Y Igarashi; Jens D Lundgren; James H Shelhamer; M A Kaliner; M V White
Effects of inhibitors of arachidonic acid metabolism on serotonin release from rat basophilic leukemia cells.
Immunopharmacology 1993;25(2):131-44.
1993: Bettina Lundgren; M Lebech; K Lind; Jens Ole Nielsen; Jens D Lundgren
Antibody response to a major human Pneumocystis carinii surface antigen in patients without evidence of immunosuppression and in patients with suspected atypical pneumonia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(2):105-9.
1992: Jens D Lundgren
Mucus production in the lower airways. A review of experimental studies.
Danish medical bulletin 1992;39(4):289-303.
1992: G Y Lipschik; Vee J Gill; Jens D Lundgren; V A Andrawis; N A Nelson; J O Nielsen; Frederick P Ognibene; Joseph A Kovacs
Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood.
Lancet 1992;340(8813):203-6.
1992: Jens D Lundgren; J N Baraniuk
Mucus secretion and inflammation.
Pulmonary pharmacology 1992;5(2):81-96.
1992: Bettina Lundgren; Jens D Lundgren; T Nielsen; L Mathiesen; Jens Ole Nielsen; J A Kovacs
Antibody responses to a major Pneumocystis carinii antigen in human immunodeficiency virus-infected patients with and without P. carinii pneumonia.
The Journal of infectious diseases 1992;165(6):1151-5.
1992: Y Igarashi; Jens D Lundgren; M E Doerfler; James H Shelhamer; M A Kaliner; M V White
Human neutrophil-derived histamine-releasing activity (HRA-N) causes the release of serotonin but not arachidonic acid metabolites from rat basophilic leukemia cells.
The Journal of allergy and clinical immunology 1992;89(6):1085-97.
1992: Joaquim Mullol; R D Rieves; James N Baraniuk; Jens D Lundgren; M Mérida; J H Hausfeld; James H Shelhamer; M A Kaliner
The effects of neuropeptides on mucous glycoprotein secretion from human nasal mucosa in vitro.
Neuropeptides 1992;21(4):231-8.
1992: Joaquim Mullol; G D Raphael; Jens D Lundgren; James N Baraniuk; M Mérida; James H Shelhamer; M A Kaliner
Comparison of human nasal mucosal secretion in vivo and in vitro.
The Journal of allergy and clinical immunology 1992;89(2):584-92.
1992: TL Nielsen; J K Eeftinck Schattenkerk; B N Jensen; Jens D Lundgren; Jan Gerstoft; RP van Steenwijk; K Bentsen; P H Frissen; J Gaub; M Orholm
Adjunctive corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS: a randomized European multicenter open label study.
Journal of acquired immune deficiency syndromes 1992;5(7):726-31.
1991: R D Rieves; Jens D Lundgren; Carolea Logun; Tiyun Wu; James H Shelhamer
Effect of protein kinase C activating agents on respiratory glycoconjugate release from feline airways.
The American journal of physiology 1991;261(6 Pt 1):L415-23.
1991: Tiyun Wu; Jens D Lundgren; R D Rieves; M E Doerfler; Carolea Logun; James H Shelhamer
Platelet-activating factor stimulates eicosanoid production in cultured feline tracheal explants.
Experimental lung research 1991;17(6):1079-94.
1991: J Vestbo; Jens D Lundgren; J Gaub; B Røder; E Gutschik
Severe Rhodococcus equi pneumonia: case report and literature review.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(9):762-8.
1991: Jens D Lundgren; Jørgen Vestbo; J Junge; L R Mathiesen
CMV pneumonia and response to ganciclovir treatment in an AIDS patient.
Respiratory medicine 1991;85(5):437-9.
1991: Jens D Lundgren; Richard Davey; B Lundgren; Joaquim Mullol; Z Marom; Carolea Logun; James N Baraniuk; M A Kaliner; James H Shelhamer
Eosinophil cationic protein stimulates and major basic protein inhibits airway mucus secretion.
The Journal of allergy and clinical immunology 1991;87(3):689-98.
1991: James N Baraniuk; Jens D Lundgren; M Okayama; J Goff; Joaquim Mullol; M Merida; James H Shelhamer; M A Kaliner
Substance P and neurokinin A in human nasal mucosa.
American journal of respiratory cell and molecular biology 1991;4(3):228-36.
1990: M Orholm; W Holten-Andersen; Jens D Lundgren
Improved detection of Pneumocystis carinii by an immunofluorescence technique using monoclonal antibodies.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(12):880-5.
1990: Court Pedersen; Jan Gerstoft; P Tauris; Jens D Lundgren; Peter C Gøtzsche; M Buhl; Y Salim; K Schmidt; Jens Ole Nielsen
Trends in survival of Danish AIDS patients from 1981 to 1989.
AIDS (London, England) 1990;4(11):1111-6.
1990: James N Baraniuk; Jens D Lundgren; M Okayama; Joaquim Mullol; M Merida; James H Shelhamer; M A Kaliner
Vasoactive intestinal peptide in human nasal mucosa.
The Journal of clinical investigation 1990;86(3):825-31.
1990: James N Baraniuk; S Castellino; Jens D Lundgren; J Goff; Joaquim Mullol; M Merida; James H Shelhamer; M A Kaliner
Neuropeptide Y (NPY) in human nasal mucosa.
American journal of respiratory cell and molecular biology 1990;3(2):165-73.
1990: B Lundgren; R Cotton; Jens D Lundgren; Jennifer C Edman; Joseph A Kovacs
Identification of Pneumocystis carinii chromosomes and mapping of five genes.
Infection and immunity 1990;58(6):1705-10.
1990: Jens D Lundgren; M Kaliner; Carolea Logun; James H Shelhamer
Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway.
Agents and actions 1990;30(3-4):329-37.
1990: Court Pedersen; Ebbe Dickmeiss; J Gaub; L P Ryder; P Platz; B O Lindhardt; Jens D Lundgren
T-cell subset alterations and lymphocyte responsiveness to mitogens and antigen during severe primary infection with HIV: a case series of seven consecutive HIV seroconverters.
AIDS (London, England) 1990;4(6):523-6.
1990: James N Baraniuk; Jens D Lundgren; J Goff; David Peden; M Merida; James H Shelhamer; M Kaliner
Gastrin-releasing peptide in human nasal mucosa.
The Journal of clinical investigation 1990;85(4):998-1005.
1990: Court Pedersen; Jan Gerstoft; P Tauris; Jens D Lundgren; Peter C Gøtzsche; M Buhl; Y Salim; K Schmidt
Opportunistic infections and malignancies in 231 Danish AIDS patients.
AIDS (London, England) 1990;4(3):233-8.
1990: James N Baraniuk; Jens D Lundgren; H Mizoguchi; David Peden; A Gawin; M Merida; James H Shelhamer; M A Kaliner
Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo.
The American review of respiratory disease 1990;141(3):706-14.
1990: Jens D Lundgren; James H Shelhamer
Pathogenesis of airway mucus hypersecretion.
The Journal of allergy and clinical immunology 1990;85(2):399-417.
1990: James N Baraniuk; Jens D Lundgren; J Goff; Joaquim Mullol; S Castellino; M Merida; James H Shelhamer; M A Kaliner
Calcitonin gene-related peptide in human nasal mucosa.
The American journal of physiology 1990;258(2 Pt 1):L81-8.
1990: M Orholm; Jens D Lundgren; TL Nielsen; J Iversen
Indication for fiberoptic bronchoscopy in HIV-infected patients suspected for Pneumocystis carinii pneumonia.
Danish medical bulletin 1990;37(1):86-9.
1990: Jens D Lundgren; M A Kaliner; James H Shelhamer
Mechanisms by which glucocorticosteroids inhibit secretion of mucus in asthmatic airways.
The American review of respiratory disease 1990;141(2 Pt 2):S52-8.
1990: M Orholm; TL Nielsen; Jens Ole Nielsen; Jens D Lundgren
CD4 lymphocyte counts and serum p24 antigen of no diagnostic value in monitoring HIV-infected patients with pulmonary symptoms.
AIDS (London, England) 1990;4(2):163-6.
1990: Jens D Lundgren; James N Baraniuk; N L Ostrowski; M A Kaliner; James H Shelhamer
Gastrin-releasing peptide stimulates glycoconjugate release from feline trachea.
The American journal of physiology 1990;258(2 Pt 1):L68-74.
1989: Jens D Lundgren; M Orholm; B Lundgren; J O Nielsen; James H Shelhamer
Pulmonary disease in patients with human immunodeficiency virus infection.
Danish medical bulletin 1989;36(5):503-6.
1989: Jens D Lundgren; M Orholm; TL Nielsen; J Iversen; J Hertz; Jens Ole Nielsen
Bronchoscopy of symptom free patients infected with human immunodeficiency virus for detection of pneumocystosis.
Thorax 1989;44(1):68-9.
1989: Court Pedersen; Jens D Lundgren; T Nielsen; W H Andersen
The outcome of Pneumocystis carinii pneumonia in Danish patients with AIDS.
Scandinavian journal of infectious diseases 1989;21(4):375-80.
1989: Jens D Lundgren; Christian Wiedermann; Carolea Logun; J Plutchok; M Kaliner; James H Shelhamer
Substance P receptor-mediated secretion of respiratory glycoconjugate from feline airways in vitro.
Experimental lung research 1989;15(1):17-29.
1988: Jens D Lundgren; Fusao Hirata; Z Marom; Carolea Logun; L Steel; M Kaliner; James H Shelhamer
Dexamethasone inhibits respiratory glycoconjugate secretion from feline airways in vitro by the induction of lipocortin (lipomodulin) synthesis.
The American review of respiratory disease 1988;137(2):353-7.
1988: Jens D Lundgren; M Kaliner; Carolea Logun; James H Shelhamer
Dexamethasone reduces rat tracheal goblet cell hyperplasia produced by human neutrophil products.
Experimental lung research 1988;14(6):853-63.